Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES vs RL Prime Solution in Heart Valve Surgery
NCT05223361Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Apr 2016
- Primary completion
- Apr 2021
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetastarch in heart valve disease, sponsored by Rajaie Cardiovascular Medical and Research Center. Started Apr 2016; status: completed.
02
Drugs
hetastarch
03
Conditions
heart valve disease
Beyond the preview
Go deeper on NCT05223361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05223361.